Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa

Loading...
Thumbnail Image

Authors

Rachlis, Beth
Bakoyannis, Giorgos
Easterbrook, Philippa
Genberg, Becky
Braithwaite, Ronald Scott
Cohen, Craig R.
Bukusi, Elizabeth A.
Kambugu, Andrew
Braithwaite, Ronald Scott
Cohen, Craig R.

Journal Title

Journal ISSN

Volume Title

Publisher

PLOS ONE

Abstract

Losses to follow-up (LTFU) remain an important programmatic challenge. While numerous patient-level factors have been associated with LTFU, less is known about facility-level factors. Data from the East African International epidemiologic Databases to Evaluate AIDS (EA-IeDEA) Consortium was used to identify facility-level factors associated with LTFU in Kenya, Tanzania and Uganda. Patients were defined as LTFU if they had no visit within 12 months of the study endpoint for pre-ART patients or 6 months for patients on ART. Adjusting for patient factors, shared frailty proportional hazard models were used to identify the facility-level factors associated with LTFU for the pre- and post-ART periods. Data from 77,362 patients and 29 facilities were analyzed. Median age at enrolment was 36.0 years (Interquartile Range: 30.1, 43.1), 63.9%were women and 58.3%initiated ART. Rates (95% Confidence Interval) of LTFU were 25.1 (24.7–25.6) and 16.7 (16.3–17.2) per 100 person years in the pre-ART and post-ART periods, respectively. Facility-level factors associated with increased LTFU included secondary-level care, HIV RNA PCR turnaround time >14 days, and no onsite availability of CD4 testing. Increased LTFU was also observed when no nutritional supplements were provided (pre-ART only), when TB patients were treated within the HIV program (pre-ART only), and when the facility was open _4 mornings per week

Description

Citation

Rachlis B, Bakoyannis G, Easterbrook P, Genberg B, Braithwaite RS, Cohen CR, et al. (2016) Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa. PLoS ONE 11(8): e0159994. doi:10.1371/journal.pone.0159994

Endorsement

Review

Supplemented By

Referenced By